Publications by authors named "Shike Lou"

Claim this Profile
A
A machine learning-based predictive model for 48-week hepatitis B surface antigen seroclearance in chronic hepatitis B patients treated with pegylated interferon α-2b: prediction at week 24.
Nan Kong, Kaixia Wang, Yiling Wang, Shike Lou, Luocheng Zhou

Front Cell Dev Biol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression landscape and clinical significance of methyltransferase-like 17 in human cancer and hepatocellular carcinoma: a pan-cancer analysis using multiple databases.
Yezhou Ding, Mingyang Feng, Wanqing Chi, Xiaoyin Wang, Baoyan An, Shike Lou

Cancer Cell Int· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy.
Shike Lou, Xiaoyin Wang, Fei Yuan, Gangde Zhao, Mingyang Feng

Front Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB.
Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng

Front Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China.
Yezhou Ding, Mingyang Feng, Di Ma, Gangde Zhao, Xiaolin Wang, Shike Lou

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN.
Mingyang Feng, Kehui Liu, Gangde Zhao, Shike Lou, Baoyan An

Antiviral Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase.
Qingqing Zhao, Kehui Liu, Xiaojun Zhu, Lei Yan, Yezhou Ding, Shike Lou

Antiviral Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Yezhou Ding, Kehui Liu, Yumin Xu, Qingqing Zhao, Shike Lou

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis